Takeda Pharmaceutical Company Limited Rightofuse Assets
Takeda Pharmaceutical Company Limited (TKPHF) had Rightofuse Assets of JPY 481.49 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2025-06-25
- 2025-03-31: Rightofuse Assets 481.49B JPY.
- 2024-03-31: Rightofuse Assets 533.40B JPY.
- 2023-03-31: Rightofuse Assets 410.27B JPY.
- 2022-03-31: Rightofuse Assets 407.94B JPY.
| Period end | Rightofuse Assets |
|---|---|
| 2025-03-31 | 481.49B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 533.40B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 410.27B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 407.94B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 386.78B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 347.02B JPY 20-F · filed 2022-06-29 |